Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05214534
Other study ID # RNI 2021 MOUSTAFA
Secondary ID 2021-A01930-41
Status Completed
Phase
First received
Last updated
Start date January 10, 2022
Est. completion date April 18, 2022

Study information

Verified date November 2021
Source University Hospital, Clermont-Ferrand
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

In this study, the investigators will investigate the relationship between the blood level of SuPAR at admission to the emergency department of the Clermont-Ferrand University Hospital, and the outcome of patients after their hospitalization in a short stay unit.


Description:

SuPAR (Soluble urokinase Plasminogen Activator Receptor) is a non-specific prognostic blood biomarker related to inflammation. An elevated SuPAR value reflects significant chronic inflammation and predicts a risk of negative outcome and even short-term mortality (intra-hospital, 30 days, 90 days). Conversely, a low SuPAR value is a strong indicator of good prognosis and low risk of readmission. It is therefore of interest to know a patient's SuPAR blood level to enable the clinician to decide whether the patient should be admitted or discharged. SuPAR has been shown to be the best prognostic marker associated with the presence and progression of disease and risk of mortality. The use of SuPAR in clinical routine adds significant complementary information to the standard Early Warning Score assessment and to the classical parameters such as CRP, PCT, Lactate, ALT, Bilirubin, and CBC in the pre-admission of acute patients. Patients admitted to the emergency department will receive their usual management. We will test the added value of the SuPAR assay in the prognosis of patients' outcome at discharge.


Recruitment information / eligibility

Status Completed
Enrollment 202
Est. completion date April 18, 2022
Est. primary completion date April 18, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patient, male or female, over 18 years old - Admitted to the emergency department of the Clermont-Ferrand University Hospital for a medical reason, - Classified as FRENCH II or III by the nurse organizer of the reception management - Necessity of clinical observation in the Short Term Hospitalization Unit for final orientation decision - Requires a blood test upon arrival in the emergency department - Able to give informed non-opposition to participate in the research. - Affiliation to a Social Security system Exclusion Criteria: - Patient under guardianship or curatorship - Pregnant and breast feeding woman - Patient admitted for psychiatric pathology - Patient with a limitation of therapeutics - Refusal to participate - Patient hospitalized because of a particular social context

Study Design


Related Conditions & MeSH terms


Intervention

Other:
blood supar measurement
The supar values will be measured afterwards on the tube bottoms of the patients included in the study from their usual collection

Locations

Country Name City State
France CHU clermont-ferrand Clermont-Ferrand

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Clermont-Ferrand

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Relationship between blood supar levels and patient outcome at discharge Relation between blood supar levels measured and patient outcome at discharge evaluated as : return home = good evolution; hospitalization = bad evolution; admission to an intensive care unit or death = unfavorable evolution When the excepted 150 patients will be included, estimated 6 months
Secondary National Early Warning Score 2 (NEWS2) Score allowing the classification of the urgency of a patient. The minimum value is 0 and the maximum value is 20. Higher scores mean a worse outcome Hour 0
Secondary Modified Early Warning Score (MEWS) Score allowing the classification of the urgency of a patient. The minimum value is 0 and the maximum value is 17. Higher scores mean a worse outcome Hour 0
Secondary Blood supar levels the supar values are classifies into three categories : < 3 ng/ml : supports the referral decision. the patient's general condition is good and the prognosis is high 3-6 ng/ml : presence of pathologies and comorbidity factors. readmissions and high mortality beyond 6 months >6 ng/ml : requires special clinical attention, high risk of mortality When the excepted 150 patients will be included, estimated 6 months
Secondary Blood CRP value the CRP value will be assessed during the blood test performed as part of the classical management when the patient arrives in the emergency room Hour 0
Secondary Cardiac frequency cardiac frequency will be evaluated when the patient arrives in the emergency service as part of the classical management Hour 0
Secondary Respiratory rate respiratory rate will be evaluated when the patient arrives in the emergency service as part of the classical management Hour 0
Secondary Temperature the temperature will be evaluated when the patient arrives in the emergency service as part of the classical management Hour 0
Secondary Systolic blood pressure systolic blood pressure will be evaluated when the patient arrives in the emergency service as part of the classical management Hour 0
Secondary Diastolic blood pressure diastolic blood pressure will be evaluated when the patient arrives in the emergency service as part of the classical management Hour 0
Secondary French triage French Emergency Nurses Classification in Hospitals (FRENCH) ranks priorities from 5 to 1 (from least urgent to most urgent) according to prognosis and complexity/severity of the medical condition Hour 0
Secondary Main diagnosis retained by the physician Main diagnosis retained at the end of hospitalization
See also
  Status Clinical Trial Phase
Completed NCT05552989 - Towards Better Preparedness for Future Catastrophes - Local Lessons-learned From COVID-19
Not yet recruiting NCT04915690 - Investigation on the Practice Status of Emergency Stuff
Not yet recruiting NCT03424096 - Primary Palliative Care Education, Training, and Technical Support for Emergency Medicine N/A
Completed NCT02534324 - The Effect of Pre-discharge Blood Pressure of Patients With Asymptomatic Severe Hypertension in Emergency Department N/A
Completed NCT00991471 - The Effect of an Physician-Nurse Supplementary Triage Assistance Team on Emergency Department Patient Wait Times N/A
Recruiting NCT03257319 - Inhaled vs IV Opioid Dosing for the Initial Treatment of Severe Acute Pain in the Emergency Department Phase 3
Recruiting NCT05005117 - Laparoscopic Approach for Emergency Colon Resection N/A
Recruiting NCT03917368 - Ultrasound Evaluation of the Jugular Venous Pulse (US-JVP) N/A
Completed NCT04601922 - Qualitative Study of Long Term Cardiovascular Risk Prediction in the Emergency Department
Recruiting NCT05497830 - Machine Learning for Risk Stratification in the Emergency Department (MARS-ED) N/A
Active, not recruiting NCT06220916 - The Greek Acute Dance Injuries Registry
Recruiting NCT05543772 - Evaluation of Blood Sampling From a Pre-existed Peripheral Intravenous Catheter Line Phase 4
Recruiting NCT06072534 - Evaluation of Effectiveness of Two Different Doses of Mivacurium in Rapid Sequence Intubation N/A
Recruiting NCT05496114 - Medical Checklists in the Emergency Department N/A
Not yet recruiting NCT05528211 - Safety and Efficacy of Emergent TAVI in Patients With Severe AS
Completed NCT05818215 - Impact of the Qatar 2022 FIFA World Cup on PED Use and Misuse Patterns
Recruiting NCT04615065 - Acutelines: a Large Data-/Biobank of Acute and Emergency Medicine
Active, not recruiting NCT04648449 - Artificial Intelligence (AI) Support in Medical Emergency Calls
Active, not recruiting NCT05221697 - Effect of an ML Electronic Alert Management System to Reduce the Use of ED Visits and Hospitalizations N/A
Not yet recruiting NCT04431986 - ER2 Frailty Levels and Incident Adverse Health Events in Older Community Dwellers